272 related articles for article (PubMed ID: 22713929)
1. Acute myelogenous leukemia stem cells: from Bench to Bedside.
Felipe Rico J; Hassane DC; Guzman ML
Cancer Lett; 2013 Sep; 338(1):4-9. PubMed ID: 22713929
[TBL] [Abstract][Full Text] [Related]
2. Identifying leukemia stem cells--is it feasible and does it matter?
Lutz C; Hoang VT; Buss E; Ho AD
Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
4. Right on target: eradicating leukemic stem cells.
Krause DS; Van Etten RA
Trends Mol Med; 2007 Nov; 13(11):470-81. PubMed ID: 17981087
[TBL] [Abstract][Full Text] [Related]
5. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
Almohsen F; Al-Mudallal SS
Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
[TBL] [Abstract][Full Text] [Related]
6. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia.
Hosen N; Park CY; Tatsumi N; Oji Y; Sugiyama H; Gramatzki M; Krensky AM; Weissman IL
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11008-13. PubMed ID: 17576927
[TBL] [Abstract][Full Text] [Related]
7. Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
Ho TC; LaMere M; Stevens BM; Ashton JM; Myers JR; O'Dwyer KM; Liesveld JL; Mendler JH; Guzman M; Morrissette JD; Zhao J; Wang ES; Wetzler M; Jordan CT; Becker MW
Blood; 2016 Sep; 128(13):1671-8. PubMed ID: 27421961
[TBL] [Abstract][Full Text] [Related]
8. Leukemia stem cells.
Buss EC; Ho AD
Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620
[TBL] [Abstract][Full Text] [Related]
9. Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.
Yanagisawa B; Perkins B; Karantanos T; Levis M; Ghiaur G; Smith BD; Jones RJ
Leuk Res; 2020 Dec; 99():106477. PubMed ID: 33220589
[TBL] [Abstract][Full Text] [Related]
10. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
[TBL] [Abstract][Full Text] [Related]
11. Preferential induction of apoptosis for primary human leukemic stem cells.
Guzman ML; Swiderski CF; Howard DS; Grimes BA; Rossi RM; Szilvassy SJ; Jordan CT
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16220-5. PubMed ID: 12451177
[TBL] [Abstract][Full Text] [Related]
12. Theragnostic strategies harnessing the self-renewal pathways of stem-like cells in the acute myeloid leukemia.
Bhattacharjee R; Ghosh S; Nath A; Basu A; Biswas O; Patil CR; Kundu CN
Crit Rev Oncol Hematol; 2022 Sep; 177():103753. PubMed ID: 35803452
[TBL] [Abstract][Full Text] [Related]
13. Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia.
Xie X; Zhang W; Zhou X; Xu B; Wang H; Qiu Y; Hu Y; Guo B; Ye Z; Hu L; Zhang H; Li Y; Bai X
Oncogene; 2023 Dec; 42(50):3657-3669. PubMed ID: 37872214
[TBL] [Abstract][Full Text] [Related]
14. Leukemic stem cells as a target for eliminating acute myeloid leukemia: Gaps in translational research.
Khaldoyanidi SK; Hindoyan A; Stein A; Subklewe M
Crit Rev Oncol Hematol; 2022 Jul; 175():103710. PubMed ID: 35588936
[TBL] [Abstract][Full Text] [Related]
15. c-MPL Is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells.
Li H; Zhao N; Li Y; Xing H; Chen S; Xu Y; Tang K; Tian Z; Wang M; Rao Q; Wang J
Stem Cells; 2018 Nov; 36(11):1685-1696. PubMed ID: 30106501
[TBL] [Abstract][Full Text] [Related]
16. Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation.
Chomel JC; Bonnet ML; Sorel N; Sloma I; Bennaceur-Griscelli A; Rea D; Legros L; Marfaing-Koka A; Bourhis JH; Ame S; Guerci-Bresler A; Rousselot P; Turhan AG
Oncotarget; 2016 Jun; 7(23):35293-301. PubMed ID: 27167108
[TBL] [Abstract][Full Text] [Related]
17. Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.
Yabushita T; Satake H; Maruoka H; Morita M; Katoh D; Shimomura Y; Yoshioka S; Morimoto T; Ishikawa T
Leuk Lymphoma; 2018 Sep; 59(9):2144-2151. PubMed ID: 29251166
[TBL] [Abstract][Full Text] [Related]
18. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
19. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
Karantanos T; Jones RJ
Adv Exp Med Biol; 2019; 1139():153-169. PubMed ID: 31134500
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia stem cells: seek and destroy.
Roboz GJ; Guzman M
Expert Rev Hematol; 2009 Dec; 2(6):663-72. PubMed ID: 21082958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
